
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
This executive summary reviews the VitaK-CAC trial, which tested whether daily MK-7 supplementation could slow coronary artery calcification in adults with symptomatic coronary artery disease. Lacey Hall, MS, of Gnosis by Lesaffre covers the vitamin K2 biology behind the study, its 2-year results with MenaQ7®, and what the findings mean for formulators.







